Author(s): Agha A; Waheed W; Stiharu I; Nerguizian V; Destgeer G; Abu-Nada E; Alazzam A;

Recent years have witnessed an increased interest in the development of nanoparticles (NPs) owing to their potential use in a wide variety of biomedical applications, including drug delivery, imaging agents, gene therapy, and vaccines, where recently, lipid nanoparticle mRNA-based vaccines were developed to prevent SARS-CoV-2 causing COVID-19. NPs typical ...

Article GUID: 36800044